14 May Who Cant Take GLP-1 Drugs
Candida albicans Colonization Modulates Murine Ethanol Consumption and Behavioral Responses Through Elevation of Serum Prostaglandin E(2) and Impact on the Striatal Dopamine System
Rare cases of clinically significant delayed emptying or retained gastric contents have been noted, especially around anesthesia (see surgery section)
Clinical experience: Nasal glucagon (Baqsimi) is feasible for rescue indications, with bioavailability of approximately 30%40%, rapid onset suitable for hypoglycemia rescue, and needle-free administration important for caregivers treating unconscious patients ( Best fit: Very potent peptides requiring small doses, rescue medications where needle-free administration is valuable (hypoglycemia, opioid overdose), or CNS-targeted strategies where direct nose-to-brain access may offer advantages over systemic administration
UK Clinical Guidance Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, but many patients wonder about its effects on existing bowel conditions